LBG-1600M |
|
Phase 1 Clinical |
Suzhou Longbotai Pharmaceutical Co Ltd |
Dermatitis, Atopic |
Details
|
TT-00420/Atezolizumab |
|
Phase 1 Clinical |
|
Gastrointestinal Neoplasms |
Details
|
NIP-046 |
NIP-046 |
Phase 1 Clinical |
|
Arthritis, Rheumatoid |
Details
|
WXFL-10203614 |
WXFL-10203614 |
Phase 2 Clinical |
Wuxi Fuxin Pharmaceutical Research And Development Co Ltd, Wuxi Apptec Co Ltd |
Arthritis, Rheumatoid |
Details
|
H-018 |
H018; H-018 |
Phase 1 Clinical |
Jiangsu Carephar Pharmaceutical Co Ltd, Nanjing Shenzhou Jiamei Pharmaceutical Co Ltd |
Arthritis, Rheumatoid |
Details
|
ATI-501 |
A-201; ATI-501; ATI-50001 |
|
Rigel Pharmaceuticals Inc |
|
Details
|
MAX-40070 |
MAX-40070 |
Phase 1 Clinical |
Maxinovel Pty Ltd |
Alopecia Areata |
Details
|
ATI-502 |
A-301; ATI-502; ATI-50002 |
|
Rigel Pharmaceuticals Inc |
|
Details
|
PF-6263276 |
PF-6263276; PF-06263276 |
|
Pfizer Pharmaceuticals Ltd (China) |
|
Details
|
AZD-1480 |
AZD-1480 |
|
Astrazeneca Pharmaceutical Co Ltd |
|
Details
|
Elsubrutinib/Upadacitinib |
ABBV-599 |
Phase 1 Clinical |
Abbvie Inc |
Lupus Erythematosus, Systemic |
Details
|
GLPG-3121 |
GLPG-3121 |
Phase 1 Clinical |
Galapagos Nv |
|
Details
|
CS-12192 |
CS12192 |
Phase 1 Clinical |
Shenzhen Chipscreen Biosciences Co Ltd |
Enteritis; Alopecia Areata; Autoimmune Diseases; Graft vs Host Disease; Multiple Sclerosis; Lupus Erythematosus, Systemic; Dermatitis, Atopic |
Details
|
PG-011 |
PG-011 |
Phase 2 Clinical |
Prime Gene Therapeutics Co Ltd |
Epidermolysis Bullosa; Rhinitis, Allergic; Prurigo; Eye Diseases; Dermatitis, Atopic |
Details
|
AQ-280 |
AQ-280 |
Phase 1 Clinical |
Aqilion AB |
Eosinophilic Esophagitis |
Details
|
Tinengotinib |
TT-00420 |
Phase 2 Clinical |
TransThera Sciences (Nanjing) Inc |
Solid tumours; Biliary Tract Neoplasms; Stomach Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms; Sarcoma; Thyroid Neoplasms; Gallbladder Neoplasms |
Details
|
TLL-018 |
TLL-018 |
Phase 2 Clinical |
Tll Pharmaceutical Llc |
Chronic Urticaria; Arthritis, Rheumatoid; Psoriasis; Colitis, Ulcerative; Urticaria |
Details
|
Fingolimod/Tofacitinib |
FMX-114 |
Phase 2 Clinical |
Vyne Therapeutics Inc |
Dermatitis, Atopic |
Details
|
LNK-01002 |
LNK01002 |
Phase 1 Clinical |
Lynk Pharmaceutical (Hangzhou) Co Ltd |
Hematologic Neoplasms; Primary Myelofibrosis; Leukemia, Myeloid, Acute |
Details
|
WXSH-0150 |
WXSH-0150; TUL-01101 |
Phase 1 Clinical |
Zhuhai United Laboratories Co Ltd |
Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
VC-005 |
VC-005 |
Phase 1 Clinical |
Jiangsu Vcare Pharmatech Co Ltd |
Inflammatory Bowel Diseases; Joint Diseases; Colitis, Ulcerative; Crohn Disease; Vitiligo; Dermatitis, Atopic |
Details
|
QY201 |
QY-201; QY201 |
Phase 2 Clinical |
E-nitiate Biopharmaceuticals (Hangzhou) Co Ltd |
Alopecia Areata; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Psoriasis; Dermatitis, Atopic |
Details
|
Golidocitinib |
NC-0322; AZD-4205; DZD-4205 |
Phase 2 Clinical |
Astrazeneca Plc, Dizal (Jiangsu) Pharmaceutical Co Ltd |
Lymphoma, T-Cell, Peripheral; Lymphoma, T-Cell, Cutaneous; Carcinoma, Non-Small-Cell Lung |
Details
|
Ivarmacitinib sulfate |
SHR-0302; ARQ-252 |
Phase 3 Clinical |
Jiangsu Hengrui Medicine Co Ltd |
Non-radiographic axial spondyloarthritis; Alopecia Areata; Spondylitis, Ankylosing; Spondylarthritis; Arthritis, Rheumatoid; Colitis, Ulcerative; Hepatic Insufficiency; Arthritis, Psoriatic; Eczema; Vitiligo; Dermatitis, Atopic; Crohn Disease |
Details
|
Deuterated Ruxolitinib |
CTP-543 |
Phase 3 Clinical |
Concert |
Alopecia Areata; Kidney Diseases; Hepatic Insufficiency |
Details
|
Brepocitinib |
PF-06700841-15; PF-6700841; PF-841; PF-06700841 |
Phase 3 Clinical |
Pfizer Inc |
Alopecia; Alopecia Areata; Dermatomyositis; Kidney Diseases; Lupus Erythematosus, Systemic; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Hidradenitis Suppurativa; Dermatitis, Atopic; Vitiligo; Crohn Disease |
Details
|
Itacitinib |
INCB-039110-adipate; INCB-39110; INCB-039110; IBI-377 |
Phase 3 Clinical |
Incyte Corp |
Lymphoma; Psoriasis; Hemic and Lymphatic Diseases; Thrombocytosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Sarcoma; Colitis, Ulcerative; Primary Myelofibrosis; Asthma; Colorectal Neoplasms; Lymphohistiocytosis, Hemophagocytic; Sarcoma, Synovial; Lung Neoplasms; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Endometrial Neoplasms; Myelodysplastic-Myeloproliferative Diseases; Neoplasm Metastasis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Liposarcoma, Myxoid; Melanoma; Carcinoma, Renal Cell; Cytokine Release Syndrome; Leukemia; Lymphoma, B-Cell; Bronchiolitis Obliterans; Solid tumours; Head and Neck Neoplasms; Chondrosarcoma; Leiomyosarcoma; Polycythemia Vera; Pruritus; Hematologic Neoplasms; Arthritis, Rheumatoid; Graft vs Host Disease; Hodgkin Disease; Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Myeloproliferative Disorders; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Liposarcoma |
Details
|
LW-402 |
LW-402 |
Phase 2 Clinical |
Shanghai Longwood Biopharmaceuticals Co Ltd |
Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
Povorcitinib |
INCB-54707; INCB54707; INCB054707; INCB-054707 |
Phase 3 Clinical |
Incyte Corp |
Renal Insufficiency; Kidney Diseases; Prurigo; Hidradenitis Suppurativa; Vitiligo |
Details
|
FZJ-003 |
FZJ-003 |
Phase 1 Clinical |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd |
Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
LNK-01001 |
LNK01001; LNK-01001 |
Phase 2 Clinical |
Lynk Pharmaceutical (Hangzhou) Co Ltd |
Spondylitis, Ankylosing; Arthritis, Rheumatoid; Dermatitis, Atopic |
Details
|
ATI-1777 |
|
Phase 2 Clinical |
Aclaris Therapeutics Inc |
Dermatitis, Atopic |
Details
|